Breaking News

You are here » Indian-Commodity  :  Commodities  :  Other Commodities  :  Soybean futures trade marginally higher on NCDEX

09-Aug2018

Soybean futures trade marginally higher on NCDEX

Soybean futures traded marginally higher on NCDEX, as speculators enlarged their positions due to steady improvement in demand from the oil mills. However, area under soybean in the country increased by 10.6% at 10.9 lakh ha as of last week compared to last year sowing, capped some gains.

The contract for October delivery was trading at Rs 3357.00, up by 0.15% or Rs 5.00 from its previous closing of Rs 3352.00. The open interest of the contract stood at 53790 lots.

The contract for November delivery was trading at Rs 3355.00, up by 0.15% or Rs 5.00 from its previous closing of Rs 3350.00. The open interest of the contract stood at 26220 lots on NCDEX.


Related News

View all news

Nickel futures edge higher on improved demand

Nickel futures edged higher on MCX as participants enlarged their holdings on the back of improved demand from alloy-makers and other consuming industries at the spot market. The contract for October delivery......

Nickel futures edge higher on improved demand

Nickel futures edged higher on MCX as participants enlarged their holdings on the back of improved demand from alloy-makers and other consuming industries at the spot market. The contract for October delivery......

Coriander futures edge higher on improved demand

Coriander futures edged higher on NCDEX as participants built up fresh positions on the back of improved demand at the spot market. Further, tight supplies from major producing regions also fuelled the......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......